Where I see patients (1)
Selected research
-
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma.
Cell reports
-
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma.
Drugs
-
Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms.
eLife
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-9888